Dnipro — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Revalia Bio uses AI to convert donated human organs and tissues into multi-modal biological datasets and decision-ready insights for drug and device development.
AI & Machine LearningBiotechHealthtechNew Haven, US
Greg Tietjen(Co-Founder & Chief Executive Officer)inJenna DiRito(Co-Founder)Kourosh Saeb-Parsy(Co-Founder)Helen Hughes(Co-Founder & Chief People Officer)Peter Buniak(Co-Founder & Advisor)Jenna DiRito, PhD(Founder)in
Co-investorsAmerica's Frontier FundConnecticut InnovationsSierra VenturesBoxOne VenturesEntrepreneur First
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.